Clinicopathological findings for adenocarcinoma of the esophagogastric junction

被引：0

作者：

Kubota, H. ^{[1
]}

Matsumoto, H. ^{[1
]}

Kaida, Y. ^{[1
]}

Murakami, H. ^{[1
]}

Higashida, H. ^{[1
]}

Hirabayashi, Y. ^{[1
]}

Oka, Y. ^{[1
]}

Okumura, H. ^{[1
]}

Urakami, A. ^{[1
]}

Yamashita, K. ^{[1
]}

Hirai, T. ^{[1
]}

Haruma, K.

机构：

[1] Kawasaki Med Sch, Dept Digest Surg, Kurashiki, Okayama 7010192, Japan

来源：

9TH INTERNATIONAL GASTRIC CANCER CONGRESS (IGCC 2011): A GATE TO THE FUTURE OF GASTRIC CANCER TREATMENT | 2011年

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The prognose for adenocarcinoma of the esophagogastric junction (AEG) is worse than that for other gastric carcinoma. Siewert et al. recommended the extended total gastrectomy for type II and type III tumors, and transhiatal esophagectomy for type I. We have experience with 40 AEG cases, in which no recurrence occurred at the stump of the esophagus. The 3-year surcical rates were 50%, 56.3%, 56.3%, and 32.1% for Stages I, IIA+IIB, III, and IV, respectively. These data indicate that, more intensive adjuvant chemotherapy might be beneficial for patients with relatively early stage disease, namely, Stages I, IIA and IIB.

引用

页码：121 / 123

页数：3

共 50 条

[11] ADENOCARCINOMA OF ESOPHAGUS AND OF ESOPHAGOGASTRIC JUNCTION
WEBB, JN
BUSUTTIL, A
BRITISH JOURNAL OF SURGERY, 1978, 65 (07) : 475 - 479
[12] EXPRESSION OF SOX9 IN ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA AND ITS CORRELATION WITH CLINICOPATHOLOGICAL CHARACTERISTICS AND PROGNOSIS
Hong, Yingcai
Wang, Zheng
Rao, Zhanpeng
Wan, Jun
Ling, Xie'an
Xu, Zhenglei
ACTA MEDICA MEDITERRANEA, 2021, 37 (01): : 195 - 199
[13] Multimodal treatment of adenocarcinoma of the esophagogastric junction
Lordick, Florian
Gockel, Ines
ONKOLOGE, 2019, 25 (12): : 1086 - 1094
[14] Treatment Options for Adenocarcinoma of the esophagogastric Junction
Lang, Hauke
ONKOLOGE, 2019, 25 (12): : 1045 - 1045
[15] Prognostic Factors for Adenocarcinoma of Esophagogastric junction
Chan, Fion S.
Tong, Daniel K.
Wong, Kam H.
Law, Simon
GASTROENTEROLOGY, 2011, 140 (05) : S1016 - S1016
[16] The postoperative complication for adenocarcinoma of esophagogastric junction
Zhang, Hui
Meng, Xianglin
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (05) : C122 - C124
[17] Pathophysiology of adenocarcinoma of the esophagogastric junction (AEGJ)
Liotta, L.
Quante, M.
ONKOLOGE, 2019, 25 (12): : 1055 - 1064
[18] ADENOCARCINOMA OF THE LOWER ESOPHAGUS AND THE ESOPHAGOGASTRIC JUNCTION
POTET, F
FLEJOU, JF
GERVAZ, H
PARAF, F
SEMINARS IN DIAGNOSTIC PATHOLOGY, 1991, 8 (03) : 126 - 136
[19] Endoscopic findings of esophagogastric junction in children
Nakayama, Yoshiko
Ida, Shinobu
DIGESTIVE ENDOSCOPY, 2017, 29 : 11 - 17
[20] Expression of Ki-67 Protein in Adenocarcinoma of Esophagogastric Junction and its Correlation with Clinicopathological Features and Prognosis
Wu, C. Y.
Huang, Z. R.
Chen, R. P.
Lin, W. P.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 : 127 - 134

← 1 2 3 4 5 →